Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
C3is | CISS | 8. oct 2024 | 1.10 | -0.90 |
C4 Therapeutics | CCCC | 8. oct 2024 | 5.13 | -0.39 |
Cabaletta Bio | CABA | 8. oct 2024 | 4.34 | +8.23 |
Cabana Target Drawdown 10 ETF | TDSC | 8. oct 2024 | 25.38 | +0.02 |
Cabana Target Drawdown 7 ETF | TDSB | 8. oct 2024 | 22.57 | -0.07 |
Cable One | CABO | 8. oct 2024 | 316.06 | -4.40 |
Cabot | CBT | 8. oct 2024 | 110.54 | -0.23 |
CACI International A | CACI | 8. oct 2024 | 512.36 | +1.18 |
Cactus A | WHD | 8. oct 2024 | 62.46 | -2.77 |
Cactus Acquisition 1 A | CCTS | 8. oct 2024 | 11.50 | 0.00 |
Cadeler ADR | CDLR | 8. oct 2024 | 28.08 | -0.35 |
Cadence Bank | CADE | 8. oct 2024 | 30.81 | -0.84 |
Cadence Bank A | CADE-A | 8. oct 2024 | 22.81 | +0.40 |
Cadence Design Systems | CDNS | 8. oct 2024 | 270.15 | +2.77 |
Cadiz | CDZI | 8. oct 2024 | 3.07 | +1.66 |
Cadiz Pref ADR | CDZIP | 8. oct 2024 | 14.95 | -0.33 |
Cadre | CDRE | 8. oct 2024 | 39.10 | +0.72 |
Cadrenal Therapeutics | CVKD | 8. oct 2024 | 12.38 | +3.17 |
Cae | CAE | 8. oct 2024 | 18.24 | -0.60 |
Caesars Entertainment | CZR | 8. oct 2024 | 43.24 | -2.81 |
Caesarstone | CSTE | 8. oct 2024 | 4.39 | -4.36 |
Cal-Maine Foods | CALM | 8. oct 2024 | 87.40 | +1.05 |
Calamos Convertible High Fund | CHY | 8. oct 2024 | 12.08 | +0.33 |
Calamos Convertible Opportunities And Income Fund | CHI | 8. oct 2024 | 11.85 | +1.89 |
Calamos Dynamic Convertible & Income Fund | CCD | 8. oct 2024 | 25.84 | +1.89 |
Calamos Global Dynamic Fund | CHW | 8. oct 2024 | 7.19 | +0.14 |
Calamos Global Total Return Fund | CGO | 8. oct 2024 | 12.17 | -1.38 |
Calamos Longshort Equity & Dynamic Income Trust | CPZ | 8. oct 2024 | 15.73 | +0.06 |
Calamos Strategic Total Return Fund - Closed End Fund | CSQ | 8. oct 2024 | 17.38 | +0.58 |
Calavo Growers | CVGW | 8. oct 2024 | 28.59 | -0.73 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.